Market Leads & Opportunities
United Kingdom-Cheshire: NHS Framework Agreement for Glatiramer acetate injection – North of England – Framework Lead
The current contract for NHS Framework Agreement for Glatiramer acetate injection – North of England – Framework Lead is projected to end on 28-FEB-22 and may be available for retender. NHS Framework Agreement for the supply of Glatiramer Acetate injection to the North of England region.
Offer reference number: CM/PHR/18/5565
Period of Framework Agreement: 1.9.2018 – 29.2.2020 with an option to extend at the Authority’s discretion for up to 24 months.
The Framework is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above.
More Market Leads
- Committee to decide on more than 100 homes in Somerset
26 Feb 25
Plans for more than 100 homes in Somerset will go before committee today (25 February). - Funding for Argyll and Bute housing projects
26 Feb 25
The UK Government has committed to delivering a package of support from the CRP to Argyll and Bute Council totalling £20.34 million. - Lead developer sought for city centre redevelopment
26 Feb 25
Hull City Council says it has taken a step forward on its redevelopment of the former BHS building in the city centre.
- In association with::
